Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Howaldt

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|October 22, 2016
A retrospective analysis of preoperative staging modalities for oral squamous cell carcinomaCh Kähling, T Langguth, F Roller, et al.
Vox Sanguinis|November 17, 2007
Topical use of platelet-rich plasma to influence bone volume in maxillary augmentation: a prospective randomized trialH Schaaf, P Streckbein, S Lendeckel, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECTR P Baum, S Adams, J Kiefer, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|October 22, 2016
A retrospective analysis of preoperative staging modalities for oral squamous cell carcinomaCh Kähling, T Langguth, F Roller, et al.
Vox Sanguinis|November 17, 2007
Topical use of platelet-rich plasma to influence bone volume in maxillary augmentation: a prospective randomized trialH Schaaf, P Streckbein, S Lendeckel, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECTR P Baum, S Adams, J Kiefer, et al.
Pageof 6